Viewing Study NCT05683834

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:27 AM

Ignite Modification Date: 2026-03-03 @ 6:32 AM

Study NCT ID: NCT05683834

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-11-21

First Post: 2023-01-12

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module